scout.yahoo.com
Yahoo Scout
Yahoo Scout
cco和sta模块
Searching…
Web results
cn.clinicaloptions.com
cn.clinicaloptions.com
Explore innovative medical education programs and resources for healthcare professionals to enhance knowledge, clinical competence, and patient care.
events.clinicaloptions.com
events.clinicaloptions.com
events.clinicaloptions.com
clinicaloptions.com
Content - ASH 2023 Multiple Myeloma | CCO
Mar 7, 2024 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.
clinicaloptions.com
CDK4/6 Inhibitors in Breast Cancer: An Oncology Nurse’s Toolkit...
Aug 15, 2025 · In this certified on-demand webcast, an expert discusses the role of oncology nurses in managing breast cancer with CDK4/6 inhibitors, covering clinical trial evidence, treatment selection, adverse even...
clinicaloptions.com
Content - BCL-2i AE Management | CCO
Oct 1, 2024 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.
clinicaloptions.com
Interactive Decision Support Tool - - CML IDST | CCO
Jan 7, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.
clinicaloptions.com
Content - H&N Cancer: <i>NTRK</i> Fusions | CCO
As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.
clinicaloptions.com
BELINDA: Tisagenlecleucel in R/R NHL - Slideset Download -...
Efficacy and safety results from BELINDA trial of tisagenlecleucel as second-line therapy for aggressive NHL presented at ASH 2021, as reported by Clinical Care Options (CCO)
clinicaloptions.com
Refractory CMV in SOT | CCO - clinicaloptions.com
Jul 31, 2025 · As a nationally recognized provider of continuing education for healthcare professionals, CCO develops, delivers, and evaluates a broad range of accredited, cutting-edge CME and CE opportunities.
clinicaloptions.com
Individualizing Therapy in Low-Risk MDS: New Evidence and Options...
Jun 14, 2024 · On-demand webcast of expert faculty presentation and case discussion on new and emerging therapies for treating patients with low-risk myelodysplastic syndromes, including strategies for implementing gu...